News & Press
Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received Young Researcher Award at BRAIN 2026
www.barchart.com6/22/2026·06/22/26🌐 Global
Summary
Nexalin Technology disclosed that an investigator on its recently completed Brazilian clinical study of Nexalin’s non-invasive Deep Intracranial Frequency Stimulation platform received the Young Researcher Award at the BRAIN 2026 congress. The recognition highlights clinical data showing significant, durable improvements in sleep quality, supporting the neuromodulation platform’s potential in sleep and mental health indications.
Why it matters
Recognition at a major conference for trial-related research signals growing scientific credibility for Nexalin's approach, useful validation as the company pursues broader international clinical and regulatory milestones.
#Neuromodulation#Neurostimulation#Sleep Tech#Depression#Clinical Trial
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in